Association between attitude toward medication and neurocognitive function in schizophrenia

被引:24
|
作者
Kim, Sung-Wan
Shin, Il-Seon
Kim, Jae-Min
Yang, Su-Jin
Shin, Hee-Young
Yoon, Jin-Sang
机构
[1] Chonnam Natl Univ, Dept Psychiat, Sch Med, Kwangju 501746, South Korea
[2] Chonnam Natl Univ Hosp, Clin Trial Ctr, Kwangju, South Korea
关键词
attitude toward medication; schizophrenia; DAI; neurocognitive function; WCST;
D O I
10.1097/01.WNF.0000228173.08885.65
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: A patient's attitude toward medication is important for medication adherence, which is a key determinant of outcome in schizophrenia. This study examined the association between attitude toward antipsychotic medication and clinical status, particularly neurocognitive function, in patients with schizophrenia. Methods: Ninety-two patients meeting the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria for schizophrenia participated in this study. The attitudes of the subjects toward medication were evaluated using the Drug Attitude Inventory (DAI). Clinical characteristics, including psychiatric symptoms and side effects of medication were evaluated. Neurocognitive function was measured using the Mini Mental State Examination and a computerized battery consisting of the Digit Span Test, Verbal Learning Test, Continuous Performance Test, Wisconsin Card Sorting Test, Finger Tapping Test, and Trail Making Test, parts A and B. The associations between attitude toward medication and neurocognitive function and clinical characteristics were analyzed. Results: The scores on the DAI were not significantly correlated with the clinical characteristics, such as psychopathology, subjective well-being, or neuroleptic-induced extrapyramidal side effects. instead, the scores on the DAI were significantly correlated with the learning index and delayed free recall on the verbal Learning Test, the number of categories completed on the Wisconsin Card Sorting Test, and omission and commission errors on the Continuous Performance Test; the scores were not significantly correlated with measures on the Mini Mental State Examination, Digit Span Test, Finger Tapping Test, or Trail Making Test. Conclusions: Our findings indicate that a patient's attitude toward medication is associated with neurocognitive function. Specifically, verbal learning memory, executive functioning, and sustained attention were associated with attitude toward medication.
引用
收藏
页码:197 / 205
页数:9
相关论文
共 50 条
  • [21] New evidence for association between COMT gene and prefrontal neurocognitive functions in schizophrenia
    Rosa, A
    Zarzuela, A
    Cuesta, M
    Peralta, V
    Martínez-Larrea, A
    Serrano, F
    Fañanás, L
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 69 - 70
  • [22] BEHAVIOR AS A FUNCTION OF ATTITUDE TOWARD OBJECT AND ATTITUDE TOWARD SITUATION
    ROKEACH, M
    KLIEJUNA.P
    JOURNAL OF PERSONALITY AND SOCIAL PSYCHOLOGY, 1972, 22 (02) : 194 - &
  • [23] Does neurocognitive function affect cognitive bias toward an emotional stimulus? Association between general attentional ability and attentional bias toward threat
    Hakamata, Yuko
    Matsui, Mie
    Tagaya, Hirokuni
    FRONTIERS IN PSYCHOLOGY, 2014, 5
  • [24] EXECUTIVE FUNCTION PERFORMANCE AS NEUROCOGNITIVE DIFFERENTIATING MARKER BETWEEN SCHIZOPHRENIA AND PSYCHOTIC DEPRESSION
    Rady, A.
    Elsheshai, A.
    Elkholy, O.
    el Wafa, H. Abou
    EUROPEAN PSYCHIATRY, 2011, 26
  • [25] The effects of olanzapine on neurocognitive functioning in medication-refractory schizophrenia
    Smith, RC
    Infante, M
    Singh, A
    Khandat, A
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2001, 4 (03): : 239 - 250
  • [26] Association between Medication Adherence and Duration of Outpatient Treatment in Patients with Schizophrenia
    Tarutani, Seiichiro
    Kikuyama, Hiroki
    Ohta, Munehiro
    Kanazawa, Tetsufumi
    Okamura, Takehiko
    Yoneda, Hiroshi
    PSYCHIATRY INVESTIGATION, 2016, 13 (04) : 413 - 419
  • [27] Medication adherence in schizophrenia; Separating attitude from behavior
    Weiden, P. J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S50 - S50
  • [28] ASSOCIATION BETWEEN POLYGENIC RISK SCORE FOR SCHIZOPHRENIA AND NEUROCOGNITIVE MEASURES IN THE WESTERN AUSTRALIAN FAMILY STUDY OF SCHIZOPHRENIA (WAFSS)
    McCarthy, Nina
    Clark, Melanie
    Cadby, Gemma
    Blangero, John
    Dragovic, Milan
    Melton, Phillip
    Moses, Eric
    Badcock, Johanna
    Jablensky, Assen
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S505 - S506
  • [29] Positive association between insight and attitudes toward medication in Japanese patients with schizophrenia: Evaluation with the Schedule for Assessment of Insight (SAI) and the Drug Attitude Inventory-10 Questionnaire (DAI-10)
    Ito, Satsuki
    Matsumoto, Junya
    Sakai, Yoshie
    Miura, Kenichiro
    Hasegawa, Naomi
    Yamamori, Hidenaga
    Ishimaru, Keiichiro
    Kim, Yoshiharu
    Hashimoto, Ryota
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2021, 75 (05) : 187 - 188
  • [30] THERAPISTS ATTITUDE TOWARD METHODS OF TREATMENT IN SCHIZOPHRENIA
    TUMA, AH
    MAY, PRA
    AMERICAN PSYCHOLOGIST, 1964, 19 (07) : 517 - 518